A representative for TE Asia declined to comment.
TE Asia Healthcare Partners is considering selling its oncology centres in Hong Kong, according to people with knowledge of the matter.
The Singapore-based company, backed by private equity firm TPG Inc., is working with a financial adviser on a potential divestment that could value Hong Kong Integrated Oncology Centre at more than US$100 million ($136.1 million), the people said. Deliberations are ongoing and TE Asia could still opt to hold onto the asset, the people said, asking not to be identified as the process is private.
